New inhaled therapies for viral infections

News Hits: 489

One of our customers, Activoris Medizintechnik GmbH, today announced the strategic collaboration with CytoTools AG (ISIN DE000A0KFRJ1) for the development of respiratory treatments against diseases like COVID-19 and Influenza. ACliRA Consulting GmbH will be supporting this development with its expertise in scientific and regulatory strategy advice. See more details here...

Print